Danielle Goudreau, PHARMD Pharmacist - Ambulatory Care Medicare: Not Enrolled in Medicare Practice Location: 5698w Us Highway 2, Manistique, MI 49854 Phone: 906-341-9546 |
Dr. Amanda Pletcher, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 717 E Lakeshore Dr, Manistique, MI 49854 Phone: 906-341-3994 Fax: 906-341-3996 |
Mr. Mark A Rohde, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 211 S Cedar Street, Manistique, MI 49854 Phone: 906-341-5494 |
Dr. Kourtney Bria Bradley, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5698 W. Us-2, Manistique, MI 49854 Phone: 906-341-9545 Fax: 906-341-1321 |
Mr. Daniel Michalik, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 Main St, Manistique, MI 49854 Phone: 906-341-3249 |
News Archive
Building on the strengths of two institutions separated by nearly 9,000 miles over two continents - both renowned in their work in the fight against cancer - the United States Agency for International Development has awarded a $500,000 grant to Fred Hutchinson Cancer Research Center to aid in the construction of the first American cancer clinic and medical-training facility in Africa.
Christopher Colbert, assistant professor of biochemistry at North Dakota State University, Fargo, has received a $348,000 grant award from the National Institute of General Medical Sciences of the National Institutes of Health to conduct research on structure-function relationships of iron transport and transcriptional regulation in Gram-negative bacteria.
Treatment-free remission may be feasible in many patients with chronic myeloid leukaemia, say researchers who set out clinical and logistical requirements for discontinuing tyrosine kinase inhibitor therapy.
Columbia University Medical Center and University of Iowa scientists have used a new gene-editing technology called CRISPR, to repair a genetic mutation responsible for retinitis pigmentosa (RP), an inherited condition that causes the retina to degrade and leads to blindness in at least 1.5 million cases worldwide.
Roche announced today that it has received FDA approval for the cobas HIV-1 viral load test by the United States Food and Drug Administration for use on the cobas 6800 and cobas 8800 Systems. This HIV-1 viral load test is part of the next generation of Roche viral load tests, which clinicians use to manage the disease and treatment of patients infected with HIV-1.
› Verified 5 days ago